Sophie Guillemard
YOU?
Author Swipe
View article: Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [<scp><sup>18</sup>F</scp>]<scp>FDG PET</scp>/<scp>CT</scp>, 20 Years After Primary Diagnosis: A Case Report
Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [<span><sup>18</sup>F</span>]<span>FDG PET</span>/<span>CT</span>, 20 Years After Primary Diagnosis: A Case Report Open
Invasive lobular carcinoma (ILC) of the breast is a rare subtype of breast cancer with distinct metastatic patterns. Although gastrointestinal metastases are rare, they can occur years after initial treatment. This case highlights the diag…
View article: Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study Open
Background New therapeutic options are needed for biliary tract cancer (BTC). Regorafenib, a multikinase inhibitor, shows promise in refractory digestive cancers and may be beneficial with conventional chemotherapy for BTC. Patients and Me…
View article: Gastric metastases from invasive breast lobular carcinoma, identified by [18F]FDG PET/CT, 20 years after primary diagnosis: A case report
Gastric metastases from invasive breast lobular carcinoma, identified by [18F]FDG PET/CT, 20 years after primary diagnosis: A case report Open
View article: Identification of 18F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
Identification of 18F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer Open
18F-FDG PET-CT is routinely performed as part of the initial staging of numerous cancers. Other than having descriptive, predictive and prognostic values for tumors, 18F-FDG PET-CT provides full-body data, which could inform on concurrent …
View article: Ureteropelvic junction obstruction with primary lymphoedema associated with <i>CELSR1</i> variants
Ureteropelvic junction obstruction with primary lymphoedema associated with <i>CELSR1</i> variants Open
Background Primary lymphoedema (PL) is a chronic, debilitating disease caused by developmental and functional defects of the lymphatic system. It is marked by an accumulation of interstitial fluid, fat and tissue fibrosis. There is no cure…
View article: Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool? Open
This study showed the reliability of HBS for the preoperative functional assessment of patients with colorectal liver metastases. Indeed, it allowed performing major hepatectomy safely in 20% more patients who would not have been considere…
View article: Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?
Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean? Open
A 48-year-old woman was referred for a bone scan as an assessment of bone metastasis from breast cancer. Surprisingly, two hot spots of lung uptake were present in the left lung without any abnormality on CT slices. No history of pulmonary…
View article: Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study Open
View article: Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study) Open
See an invited perspective on this article on page 1043.This multicenter phase II study investigated a selective radiotherapy dose increase to tumor areas with significant 18F-misonidazole (18F-FMISO) uptake in patien…